Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSGU) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for BrightSpring Health Services (BTSGU) over the last 3 years, with Q3 2025 value amounting to -$10.4 million.

  • BrightSpring Health Services' Change in Account Payables fell 10914.0% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.5 million, marking a year-over-year decrease of 4038.59%. This contributed to the annual value of $303.2 million for FY2024, which is 18699.66% up from last year.
  • Per BrightSpring Health Services' latest filing, its Change in Account Payables stood at -$10.4 million for Q3 2025, which was down 10914.0% from $107.1 million recorded in Q2 2025.
  • BrightSpring Health Services' Change in Account Payables' 5-year high stood at $164.0 million during Q4 2023, with a 5-year trough of -$67.0 million in Q1 2023.
  • Its 3-year average for Change in Account Payables is $41.1 million, with a median of $21.6 million in 2024.
  • Within the past 5 years, the most significant YoY rise in BrightSpring Health Services' Change in Account Payables was 44323.67% (2025), while the steepest drop was 34934.51% (2025).
  • Over the past 3 years, BrightSpring Health Services' Change in Account Payables (Quarter) stood at $164.0 million in 2023, then decreased by 9.95% to $147.6 million in 2024, then plummeted by 107.07% to -$10.4 million in 2025.
  • Its Change in Account Payables was -$10.4 million in Q3 2025, compared to $107.1 million in Q2 2025 and -$53.9 million in Q1 2025.